openPR Logo
Press release

Injectable Drug Delivery Market Technological Advancements to aid Growth by 2021

08-07-2017 03:10 PM CET | Health & Medicine

Press release from: Persistence Market Research

Injectable Drug Delivery Market Technological Advancements

Drug delivery is the process of administering a pharmaceutical compound into the body through various routes to achieve a therapeutic effect. Oral, injection-based, transdermal, and carrier-based are some of the types of drug delivery devices. Injectable drug delivery facilitates the rapid transport of a drug into the body by bypassing first-pass metabolism. It also helps in administering drugs in unconscious and comatose patients. Injectable drug delivery is used in conditions such as hormonal imbalance, cystic fibrosis, autoimmune diseases, pain, Wilson’s disease, hemophilia, hepatitis C, and ribose-5-phosphate isomerase deficiency. Toxicity due to incorrect dosing, invasive, and sterility are some of the disadvantages of injectable drug delivery systems. Injectable drug delivery technologies are categorized into device technologies and formulation technologies. Injectable drug delivery device technologies are further categorized into conventional injection devices, self-injection devices such as injectors and pen injectors, and others such as micro-needle, blunt needle, and nano-needle injections. On the other hand, injectable drug delivery formulations are further categorized into novel drug delivery formulation and conventional drug delivery formulation.

To View Complete Report @ : http://www.persistencemarketresearch.com/market-research/injectable-drug-delivery-market.asp

North America dominates the global market for injectable drug delivery due to a large aging population and increasing incidences of diabetes. Asia is expected to witness high growth rates in the next five years in the global injectable drug delivery market. China and India are expected to be the fastest-growing injectable drug delivery markets in Asia Pacific. Some of the key driving factors of the injectable drug delivery market in emerging countries are a large pool of patients, increasing healthcare expenditure, rising focus of various huge players, increasing healthcare awareness, and rising government funding.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3774


In the recent years, the use of injectable drug delivery has increased due to increasing incidences of cancer and diabetes. Technological advancements, improving patient compliance, beneficial reimbursement policies, and rise of biologics in the pharmaceutical market are some of the key factors driving the growth of the global injectable drug delivery market. In addition, increasing healthcare awareness and increasing geriatric population are also fueling the growth of the global injectable drug delivery market. However, needlestick injuries and infections, and introduction of alternative drug delivery methods are some of the major factors restraining the growth of the global injectable drug delivery market. In addition, regulatory requirements for the approval of devices would also restrain the growth of the global injectable drug delivery market.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/3774

Less stringent regulatory policies and less data requirement for approval of devices are expected to drive the growth of the injectable drug delivery market in Asia. Development of biosimilars in the pharmaceutical market would create opportunities for the global injectable drug delivery market. However, high manufacturing cost and sustainability of players in the highly competitive market could pose a challenge for the global injectable drug delivery market. Innovations in injectable drug delivery systems are the trend for the global injectable drug delivery market. Some of the major companies operating in the global injectable drug delivery market are Nova Nordisk A/S, Sanofi, Crossject, Eli Lilly and Company, Baxter International, Inc., Becton, Dickinson and Company, InjexPharma GmbH, Elcam Medical, Unilife Corporation, West Pharmaceutical Services, Inc., and Vetter Pharma-Fertigung GmbH & Co. KG.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Injectable Drug Delivery Market Technological Advancements to aid Growth by 2021 here

News-ID: 658020 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for Injectable

Key Small Molecule Injectable Drugs Market Trend for 2025-2034: Small Molecule I …
What Is the Future Outlook for the Small Molecule Injectable Drugs Market's Size and Growth Rate? The small molecule injectable drugs market has grown rapidly in recent years. It will rise from $219.57 billion in 2024 to $248.2 billion in 2025, at a CAGR of 13.0%. The growth is attributed to the rising prevalence of chronic diseases, an aging population, government initiatives, increased healthcare spending, and improvements in manufacturing processes. The small
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Facial Injectable Market Size to Hit $7.5 Billion by 2028 | Facial Injectable In …
According to our experience research team, Facial Injectable Market was valued at USD 4.4 Billion in 2021, and the global Facial Injectable industry is projected to reach a value of USD 7.5 Billion by 2028, at a CAGR of 9.4% during the forecast period 2022-2028 The report is focused on gaining various Facial Injectable market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the global
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis. The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that
Global Injectable Drug Delivery Devices Market | Global Injectable Drug Delivery …
The injectable drug delivery devices market involves of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors. The market contains the sales of the Injectable devices that have been comprehensively utilized for several routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and several others to cure the medical conditions vacillating from cancer to autoimmune disorders. The injectable drug delivery devices utilized in hospitals, clinics
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of